Trademark: 90611009
Word
ONCOLIPIN
Status
Pending
Status Code
733
Status Date
Thursday, February 15, 2024
Serial Number
90611009
Mark Type
4000
Filing Date
Monday, March 29, 2021
Published for Opposition
Tuesday, December 21, 2021
Trademark Owner History
XEME Biopharma, Inc. - Owner At Publication
Classifications
5 Drug delivery agents consisting of compounds that facilitate delivery of a wide range of pharmaceuticals, immunotherapies and antigens
Trademark Events
Feb 16, 2024
Notice Of Approval Of Extension Request E-Mailed
Feb 15, 2024
Sou Extension 4 Granted
Feb 15, 2024
Sou Extension 4 Filed
Feb 15, 2024
Sou Teas Extension Received
Aug 17, 2023
Notice Of Approval Of Extension Request E-Mailed
Aug 15, 2023
Sou Extension 3 Granted
Aug 15, 2023
Sou Extension 3 Filed
Aug 15, 2023
Sou Teas Extension Received
Feb 17, 2023
Notice Of Approval Of Extension Request E-Mailed
Feb 15, 2023
Sou Extension 2 Granted
Feb 15, 2023
Sou Extension 2 Filed
Feb 15, 2023
Sou Teas Extension Received
Aug 17, 2022
Notice Of Approval Of Extension Request E-Mailed
Aug 15, 2022
Sou Extension 1 Granted
Aug 15, 2022
Sou Extension 1 Filed
Aug 15, 2022
Sou Teas Extension Received
Feb 15, 2022
Noa E-Mailed - Sou Required From Applicant
Dec 21, 2021
Official Gazette Publication Confirmation E-Mailed
Dec 21, 2021
Published For Opposition
Dec 1, 2021
Notification Of Notice Of Publication E-Mailed
Nov 12, 2021
Approved For Pub - Principal Register
Nov 5, 2021
Assigned To Examiner
Jul 6, 2021
New Application Office Supplied Data Entered
Apr 1, 2021
New Application Entered
SENFOT
RXIPEAW
Trademark Alertz updated from USPTO on 2030-01-24

Trademark Alertz ™ - GRJR PTY LTD 2024 - Privacy Policy - Terms of Use

The information provided on Trademark Alertz is not legal or professional advice. Information may have been obtained from third parties and may contain errors. You must make your own enquiries and seek independent advice from relevant industry professionals before acting or relying on any information from Trademark Alertz. All trade mark information has been obtained from and made publicly available by The United States Patent and Trademark Office (USPTO). Copyright of the trademark data resides with USPTO. www.uspto.gov